Skip Navigation

Informed

Subscribe to Informed Emails

FLASH: Health Alliance Prior Authorization Changes for 2024

Each year, Health AllianceTM performs a comprehensive review and analysis around services needing prior authorization. In our last review cycle, we removed prior authorization around ultrasound, oxygen therapy, non-urgent ground ambulance and select DME items.

View Full Post

October 2023 Newsletter

As the leaves change, our gratitude never does. Autumn is a time of change. The weather’s getting colder, daylight is fading quicker into evening dusk and the trees are showcasing brilliant colors in the weeks before losing their leaves for another winter ahead. While nature is in a constant state of change, our gratitude for you never is. Across the seasons, you and your staff never rest as you provide our members the best in compassionate, world-class care. And that’s why – all year round – we’re simply beyond thankful for all that you do. As you enjoy the beauty of nature this autumn, please know how deeply grateful we are for your partnership.

View Full Post

FLASH: OSF Leaving Triple Option Plans

Recently, the contract between OSF HealthCare and Health Alliance™ came up for review between the two organizations. Health Alliance strives to offer a competitive product in the market with a tiered structure where there is reduced cost-sharing for patients when they see a Tier 1 provider. As such, there are certain contract terms that must be met to keep the product competitive in the market.

View Full Post

August 2023 Newsletter

A Word of Thanks  

View Full Post

FLASH: New Low-Cost Options for Autoimmune Disorders

A few months ago, we added a new adalimumab product, Amjevita, to the Health AllianceTM commercial formulary with prior authorization. In addition to Amjevita, Health Alliance will now be adding two new biosimilar adalimumab products, Hadlima and Adalimumab-adaz. All three biosimilars will be covered across all formularies, including Medicare, in parity with Humira. Health Alliance continues to be committed to offering members and providers access to biosimilars as they become available.

View Full Post